IGC Pharma Files Definitive Proxy Statement

TL;DR

IGC Pharma dropped its proxy statement, shareholders vote soon.

AI Summary

IGC Pharma, Inc. filed its definitive proxy statement on August 18, 2025, for the fiscal year ending March 31, 2025. The company, previously known as India Globalization Capital, Inc., is a pharmaceutical preparations company incorporated in Maryland. The filing pertains to matters requiring shareholder approval, as is typical for a DEF 14A filing.

Why It Matters

This filing provides shareholders with crucial information regarding upcoming votes and company governance, impacting their investment decisions.

Risk Assessment

Risk Level: medium — DEF 14A filings are routine but can precede significant corporate actions or shareholder votes that may impact stock price.

Key Players & Entities

• IGC Pharma, Inc. (company) — Registrant
• India Globalization Capital, Inc. (company) — Former company name
• 20250818 (date) — Filing date
• 20251010 (date) — Period of report
• 0331 (date) — Fiscal year end

FAQ

Key Financial Figures

• $4,000 — es to InvestorCom will be approximately $4,000. PROPOSAL ONE ELECTION OF DIRECTORS

Filing Documents

• igcdef14a081825.htm (DEF 14A) — 377KB
• image_001.jpg (GRAPHIC) — 6KB
• image_002.jpg (GRAPHIC) — 3KB
• 0001185185-25-001021.txt ( ) — 990KB
• igc-20250831.xsd (EX-101.SCH) — 10KB
• igc-20250831_def.xml (EX-101.DEF) — 4KB
• igc-20250831_lab.xml (EX-101.LAB) — 33KB
• igc-20250831_pre.xml (EX-101.PRE) — 3KB
• igcdef14a081825_htm.xml (XML) — 105KB

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 IGC Pharma, Inc. (Exact name of registrant as specified in its charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required. Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. IGC Pharma, Inc. 10224 Falls Road, Potomac, Maryland, 20854 ANNUAL MEETING OF STOCKHOLDERS Dear Stockholder: You are cordially invited to attend the 2025 Annual Stockholders' Meeting of IGC Pharma, Inc. ("IGC," "we," "us," "our," or the "Company"), which is to be held at 10224 Falls Road, Potomac, Maryland, 20854, on October 10, 2025, at 11:00 a.m. local time. We reserve the right to take any additional precautionary measures we deem appropriate in relation to the physical meeting and access to our premises. We may need to change the time, date, or location of the Annual Meeting. If we do so, we will announce any changes in advance as required by the Securities and Exchange Commission (the "SEC"), and by any applicable state law. The Annual Meeting will commence with a discussion and voting on the matters set forth in the accompanying Notice of Annual Meeting of Stockholders, followed by a report on our operations. The Notice of Annual Meeting of Stockholders and Proxy Statement, which more fully describes the formal business to be conducted at the Annual Meeting, follows this letter. A copy of our Annual Report to Stockholders for the fiscal year ended March 31, 2025, is also enclosed. We encourage you to carefully read these materials. The notice and the accompanying proxy statement will be mailed to all stockholders by August 25, 2025. Whether or not you plan to attend the Annual Meeting, it is important that your shares be represented and voted at the Annual Meeting. Therefore, I urge you to promptly vote and submit your proxy by signing, dating, and returning your proxy card. Beneficial owners of shares held in street name should follow the instructions in the Proxy Statement for voting their shares. If you are a record holder and you decide to attend the Annual Meeting, you will be able to vote in person, even if you have previously submitted your proxy. IMPORTANT NOTICE REGARDING THE INTERNET AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON OCTOBER 10, 2025: This Proxy Statement, the Notice of Annual Meeting of Stockholders, and our Annual Report to Stockholders are available at http://www.igcpharma.com. Except as otherwise stated, information on our website is not a part of this Proxy Statement. We will send a full set of proxy materials or a Notice of Internet Availability of Proxy Materials (the " Notice of Internet Availability " ) on or about August 25, 2025, and provide access to our proxy materials over the Internet, beginning on for the holders of record and beneficial owners of our shares of common stock as of the close of business on the record date. The Notice of Internet Availability instructs you on how to access and review this Proxy Statement and our fiscal 2025 Annual Report to Stockholders. The Notice of Internet Availability also instructs you on how you may authorize a proxy to vote your shares over the Internet and provides instructions on how you can request a paper copy of these documents if you desire, and how you can enroll in e-delivery. If you received your annual meeting materials via email, the email contains voting instructions and links to our annual report and proxy statement on the internet. On behalf of the Board of Directors, thank you for your continued support. Sincerely, /s/ Richard Prins Chairman | FYE2025 Form DEF 14A 2 IGC Pharma, Inc. 10224 Falls Road, Potomac, Maryland, 20854 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS The Annual Meeting of Stockholders (the "Annual Meeting") for the year ended March 31, 2025, of IGC Pharma, Inc. ("IGC," "we," "us," "our" or the "Company") will be held at 10224 Falls Road, Potomac, Maryland, 20854, on October 10, 2025, at 11:00 a.m. local time. Voting materials, which include this Proxy Statement, the proxy card, and our Annual Report for the fiscal year ended March 31, 2025 ("Fiscal 2025"), are first being mailed to Stockholders of the Company on or about August 25, 2025. Stockholders who desire to attend the Annual Meeting should indicate such planned attendance by ma

View Full Filing

View this DEF 14A filing on SEC EDGAR